Vimarsana
Biggest News Aggregation in the World

Page 10 - Protein Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Engineering Today - Breaking & Trending Today

Aktis Oncology Expands Leadership Team with Two Strategic Hires - Vimarsana News

Aktis Oncology Expands Leadership Team with Two Strategic Hires

/PRNewswire/ -- Aktis Oncology, a biotechnology company discovering and developing a novel class of targeted alpha radiopharmaceuticals to treat a broad range...

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therap - Vimarsana News

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therap

  Companies will work toward accessing a novel strategy for breaking the tumor microenvironment by combining ITM’s high-quality radioisotopes with Navigo’s precise target-specific affinity ligands against the fibroblast activation protein (FAP)GARCHING/MUNICH, Germany and HALLE/SAALE, Germany, December 02,...

Global FC (Fragment Crystallizable) Protein and - Vimarsana News

Global FC (Fragment Crystallizable) Protein and

Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd...

Machine learning algorithms accelerate the protein engineering process - Vimarsana News

Machine learning algorithms accelerate the protein engineering process

Proteins are the molecular machines of all living cells and have been exploited for use in many applications, including therapeutics and industrial catalysts.

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice - Vimarsana News

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

Researchers in the United States and China have developed plasmid DNA immunogens that induce effective antibody responses in mice against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).